Detalhe da pesquisa
1.
Combination Therapy With Immune Checkpoint Inhibitors in Urothelial Carcinoma: Current Data and Future Outlook.
Oncology (Williston Park)
; 35(7): 410-420, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264569
2.
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 18(11): 1483-1492, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967485
3.
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
Eur Urol Oncol
; 7(1): 83-90, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442672
4.
Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancer.
Oncologist
; 18(6): 687-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740935
5.
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.
Invest New Drugs
; 31(4): 1001-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23329066
6.
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial.
Nat Med
; 28(8): 1640-1645, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962206
7.
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077617
8.
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.
Clin Cancer Res
; 28(10): 2050-2060, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247908
9.
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Cancer
; 117(16): 3731-40, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21815133
10.
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinoma.
Invest New Drugs
; 29(2): 374-9, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20012337
11.
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.
NPJ Precis Oncol
; 5(1): 92, 2021 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667258
12.
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer.
J Clin Oncol
; 38(23): 2658-2666, 2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552471
13.
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status.
Eur Urol Oncol
; 3(3): 351-359, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423837
14.
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).
Int J Radiat Oncol Biol Phys
; 97(5): 995-1001, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333021
15.
Phase II trial of thalidomide for patients with advanced renal cell carcinoma.
J Clin Oncol
; 20(1): 302-6, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11773183
16.
Salvage chemotherapy for patients with advanced pure seminoma.
J Clin Oncol
; 20(1): 297-301, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11773182
17.
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
J Clin Oncol
; 31(32): 4092-8, 2013 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081940
18.
Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer.
Int J Radiat Oncol Biol Phys
; 82(4): e609-15, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22208976
19.
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.
Menopause
; 19(1): 48-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900849
20.
Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer.
Cancer
; 115(4): 784-91, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19130458